A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Department of Defense Adds Lipogems to Their Arsenal

Premier Medical Technology Available To Order Through DAPA

What To Know

  • We would like to recognize and thank the Geneva Foundation for the MIRROR Study evaluating Lipogems for knee issues in active military patients and Brooke Army Medical Center for evaluating Lipogems for wound victims.
  • Lipogems is a premier FDA-cleared medical technology that uses the patient's own adipose tissue (fat) and injects it into troubled areas to support the repair and healing of injured or damaged tissue.

Musculoskeletal injuries pose the greatest public health problem facing military service members during peacetime and combat. Musculoskeletal issues impact approximately 800,000 service members annually and are the greatest threat to military readiness and the primary reason for medical discharge.

The company Lipogems, is a leading global medical technology company. Today they announced that, through its partnership with Buffalo Supply, Inc., the Lipogems Sports Medicine System is now available within the U.S. Department of Defense (DoD) to help over 2.3 million service members that may be suffering from orthopaedic and wound issues.

Lipogems is a premier FDA-cleared medical technology that uses the patient’s own adipose tissue (fat) and injects it into troubled areas to support the repair and healing of injured or damaged tissue.  The simple, minimally invasive procedure uses only a local anesthetic and can be performed in the clinic, on the field, or added to surgery. For veterans with multiple issues, the fat from one harvest can be used in multiple areas in the same setting. Through the Distribution And Pricing Agreement (DAPA), Lipogems is now available at over 60 hospitals and over 400 clinics, and 2 hospital ships (USNS Mercy, USNS Comfort).

“We are proud and honored to be helping our nation’s brave active military and veterans. Currently, Lipogems is being used by military physicians with great success to help those that have tried conservative options with limited relief for their orthopaedic issues and are not ready for major invasive surgery. DAPA provides better access to the DoD medical facilities and efficient means of supporting the military for their orthopaedic, wound, and burn issues. As a responsible company, Lipogems is supported by strong scientific and clinical evidence with over 70+publications in peer-reviewed journals from leading institutions from around the world. We would like to recognize and thank the Geneva Foundation for the MIRROR Study evaluating Lipogems for knee issues in active military patients and Brooke Army Medical Center for evaluating Lipogems for wound victims. Also, we would like to thank the multiple orthopaedic physicians that have donated the Lipogems procedure to retired Special Operations, veterans, and active military. Our veterans deserve the best access to healthcare and we are proud to help the heroic men and women who serve our country.” Said Carl Llewellyn, CEO, and President of Lipogems USA. Additional information available here.

 

 

 

SourceLipogems
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.
SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.

By using this website you agree to accept Medical Device News Magazine Privacy Policy